Tolerability of Asasantin in Healthy Female and Male Subjects
NCT02269228 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2014-10-21
Summary
To investigate the occurrence of dipyridamole associated headaches in healthy subjects using a titration scheme or not
Conditions
- Healthy
Interventions
- DRUG
-
Asasantin ER
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-02-29
- Primary Completion
- 2000-04-30
More Related Trials
-
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes
NCT05105919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Alternate Dosing Regimens of BG00012 in Healthy Volunteers
NCT01281111 ·Status: COMPLETED ·Phase: PHASE1
-
Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers
NCT02226926 ·Status: COMPLETED ·Phase: PHASE1
-
IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes
NCT03574909 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
NCT05702463 ·Status: RECRUITING ·Phase: PHASE1
-
Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease
NCT01320072 ·Status: TERMINATED
-
Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin
NCT03424408 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects
NCT04588727 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Effects of Buffered and Enteric-coated Forms of Aspirin on Platelet Aggregation in Patients With Diabetes Mellitus and Chronic Coronary Syndrome
NCT06716255 ·Status: COMPLETED
-
Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?
NCT00578760 ·Status: UNKNOWN ·Phase: NA
-
Aspirin Resistance in Coronary Artery Disease
NCT00753935 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants
NCT03341390 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease
NCT00501059 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
NCT00272311 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Resistance in Trinidad.
NCT06228820 ·Status: COMPLETED ·Phase: PHASE2
-
Asprin Dosing Estimator in Healthy Adults
NCT04040465 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic Patients
NCT00812032 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.
NCT00425074 ·Status: COMPLETED ·Phase: PHASE1
-
ASPIRIN: Neurodevelopmental Follow-up Trial
NCT04888377 ·Status: COMPLETED
-
Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin
NCT01081353 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
NCT00501345 ·Status: TERMINATED ·Phase: PHASE3
-
A Healthy Female and Male Volunteers Aspirin Study
NCT01448031 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis
NCT02261025 ·Status: COMPLETED ·Phase: NA
-
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting
NCT01276691 ·Status: COMPLETED ·Phase: PHASE4
-
Chronotherapy with Low-dose Aspirin for Primary Prevention
NCT00725127 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4